  Multifunctional mesoporous silica nanoparticles (MSN) have attracted
substantial attention with regard to their high potential for targeted drug
delivery. For future clinical applications it is crucial to address safety
concerns and understand the potential immunotoxicity of these nanoparticles. In
this study, we assess the biocompatibility and functionality of multifunctional
MSN in freshly isolated, primary murine immune cells. We show that the
functionalized silica nanoparticles are rapidly and efficiently taken up into
the endosomal compartment by specialized antigen-presenting cells such as
dendritic cells. The silica nanoparticles showed a favorable toxicity profile
and did not affect the viability of primary immune cells from the spleen in
relevant concentrations. Cargo-free MSN induced only very low immune responses
in primary cells as determined by surface expression of activation markers and
release of pro-inflammatory cytokines such as Interleukin-6, -12 and -1\beta.
In contrast, when surface-functionalized MSN with a pH-responsive polymer
capping were loaded with an immune-activating drug, the synthetic Toll-like
receptor 7 agonist R848, a strong immune response was provoked. We thus
demonstrate that MSN represent an efficient drug delivery vehicle to primary
immune cells that is both non-toxic and non-inflammagenic, which is a
prerequisite for the use of these particles in biomedical applications.
